Related Experiment Videos
Sensitivity patterns of coagulase-negative staphylococci from neonates.
The Journal of Antimicrobial Chemotherapy
|February 1, 1986
Summary
Antibiotic resistance in coagulase-negative staphylococci varies between neonatal units. Netilmicin and cefamandole demonstrated the highest activity against these bacteria, highlighting the impact of local antibiotic policies.
Area of Science:
- Medical Microbiology
- Neonatal Medicine
- Infectious Disease
Background:
- Coagulase-negative staphylococci (CoNS) are significant pathogens in neonatal intensive care units.
- Antibiotic resistance patterns in CoNS can vary geographically and are influenced by local antimicrobial prescribing practices.
- Understanding these patterns is crucial for effective infection control and treatment in special care baby units.
Purpose of the Study:
- To compare the antibiotic sensitivity profiles of coagulase-negative staphylococci isolates from two special care baby units (SCBUs).
- To evaluate the impact of differing antibiotic policies on the antimicrobial resistance of CoNS in neonates.
- To identify the most effective antibiotic classes against CoNS in the studied neonatal populations.
Main Methods:
- Collection of coagulase-negative staphylococci isolates from neonates in two distinct SCBUs.
- Antimicrobial susceptibility testing against 18 different antibiotics.
- Comparison of sensitivity profiles between the two units based on their respective antibiotic policies.
Main Results:
- Significant differences in antibiotic sensitivity profiles were observed between the two SCBUs.
- Netilmicin was identified as the most potent aminoglycoside against the tested CoNS isolates.
- Cefamandole emerged as the most effective cephalosporin in terms of antimicrobial activity.
Conclusions:
- Local antibiotic policies significantly influence the antibiotic sensitivity patterns of coagulase-negative staphylococci in neonatal units.
- Netilmicin and cefamandole represent valuable therapeutic options for treating CoNS infections in neonates within these settings.
- Judicious antibiotic stewardship is essential to mitigate the development of antimicrobial resistance in vulnerable neonatal populations.